An interventional study of external angular dermoid cysts surgical removal in Dermoid Cyst and Choristomas, sponsored by Beni-Suef University. Completed at 3 sites in Egypt. Open to participants aged 1 Year to 12 Years. Per ClinicalTrials.gov, last updated 2025-02-24.
Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Purpose to evaluate the effect of alcohol used in accidentally opened dermoid cyst in prevention of inflammation and recurrence Patient and method: Itt is a comparative interventional study ,performed on 60 patients with external angular dermoid cysts that were accidentally opened during surgical removal , they were divided into two groups ,Group (A) includes 30 patients where only saline was used to wash the surgical field while group(B) includes 30 patients where ethyl alcohol 70% was used.
Study Design and Rationale:
This is a comparative interventional study designed to evaluate the efficacy of 70% ethyl alcohol in preventing inflammation and recurrence in cases of accidentally opened external angular dermoid cysts during surgical removal. The rationale for using 70% ethyl alcohol is based on its antimicrobial and antiseptic properties, which may reduce the risk of postoperative infection and cyst recurrence compared to saline irrigation alone.
Patient Recruitment and Group Allocation:
Recruitment Sites: Patients were recruited from outpatient clinics at Beni-Suef University Hospitals, Fayoum University Hospitals, and MUST University Hospital.
Recruitment Period: May 2022 to May 2024.
Group Allocation:
Group A (Control Group): 30 patients treated with saline irrigation.
Group B (Intervention Group): 30 patients treated with 70% ethyl alcohol.
Surgical Procedure:
Preoperative Preparation:
Patients were positioned supine, and the surgical site was sterilized using standard antiseptic protocols.
Local or general anesthesia was administered based on patient and surgeon preference.
Incision and Dissection:
A skin incision was made below the eyebrow, followed by subcutaneous and orbicularis dissection to expose the dermoid cyst.
Care was taken to avoid accidental rupture, but if the cyst was opened, the following steps were implemented.
Cyst Management:
The cyst walls and contents were meticulously removed from the surgical field to minimize residual material.
Group A (Saline Group): The surgical field was irrigated with sterile saline solution to remove any remnants.
Group B (Alcohol Group): The surgical field was cleaned using a gauze soaked with 70% ethyl alcohol to ensure thorough disinfection.
Wound Closure:
The wound was closed in layers using absorbable sutures for subcutaneous tissues and non-absorbable sutures or skin adhesive for the skin.
A sterile dressing was applied.
Postoperative Care:
Medications:
Both groups received the same regimen of systemic antibiotics (e.g., amoxicillin-clavulanate) and anti-inflammatory drugs (e.g., ibuprofen) for 5-7 days to prevent infection and inflammation.
Follow-Up:
Patients were monitored at 1 week, 1 month, 3 months, and 6 months postoperatively.
At each visit, the surgical site was assessed for signs of inflammation, infection, or recurrence.
Any adverse events or complications were recorded.
Data Collection and Analysis:
Data Collected:
Demographic data (age, sex).
Intraoperative details (cyst size, extent of spillage).
Postoperative outcomes (infection, inflammation, recurrence).
Statistical Methods:
Data were analyzed using SPSS version 24.
Quantitative variables (e.g., cyst size) were summarized as mean ± standard deviation.
Categorical variables (e.g., recurrence rates) were summarized as frequencies and percentages.
Comparisons between groups were performed using:
ANOVA with post hoc tests for continuous variables.
Chi-square test or Fisher's exact test for categorical variables.
Pearson correlation coefficient was used to assess relationships between quantitative variables.
A p-value \< 0.05 was considered statistically significant.
Technical Considerations:
Ethyl Alcohol Concentration: 70% ethyl alcohol was chosen for its optimal balance between antimicrobial efficacy and tissue safety.
Saline Irrigation: Sterile saline was used as a control to mimic standard surgical practice.
Standardization: All procedures were performed by experienced surgeons to ensure consistency in technique and cyst management.
Ethical and Regulatory Compliance:
Informed Consent: Written informed consent was obtained from all participants prior to surgery.
Ethical Approval: The study protocol was approved by the Ethics Committee of Beni-Suef University and adhered to the principles of the Helsinki Declaration.
Patient Safety: Adverse events were monitored and managed promptly to ensure patient safety.
Limitations:
The study is limited by its sample size (n=60), which may affect the generalizability of the results.
The follow-up period of 6 months may not be sufficient to capture long-term recurrence rates.
Potential variability in surgical technique among different surgeons.
The study aims to demonstrate that 70% ethyl alcohol is more effective than saline in reducing postoperative inflammation and recurrence in accidentally opened dermoid cysts.
If proven effective, this intervention could be incorporated into standard surgical protocols for dermoid cyst management.
Beni-Suef University is the lead sponsor of 349 studies on the registry; 123 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Clinical diagnosis of external angular dermoid cyst.
Accidental opening of the dermoid cyst during surgical removal.
Age: Patients of any age eligible for surgical intervention.
Willingness to provide written for participation in the study.
Exclusion Criteria:
Recurrent dermoid cysts (previously treated or excised).
Complicated dermoid cysts (e.g., preoperatively ruptured or infected).
Patients with to the use of ethyl alcohol (e.g., known or allergy).
Patients with systemic conditions that may impair wound healing (e.g., uncontrolled diabetes, states).
Patients who are pregnant or breastfeeding.
Patients unable or unwilling to comply with follow-up visits.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
only saline was used to wash the surgical field
Procedure: external angular dermoid cysts surgical removal
ethyl alcohol 70% was used to wash the surgical field
Procedure: external angular dermoid cysts surgical removal
Skin incision was done below the eyebrow, subcutaneous and orbicularis dissection was done to remove the cysts. Upon accidental opening of the cyst then removal of the cyst walls and its contents from the surgical field as much as possible was done. At this step, in group (A) only saline was used to wash the surgical field from any remnants. In group (B) the surgical field was cleaned with a gauze soaked with ethyl alcohol 70%. Then closure of the wound in both groups.
post-operative inflammation
The primary outcome of post-operative inflammation measures the incidence of clinically significant inflammatory responses at the surgical site following excision of an accidentally opened external angular dermoid cyst. Inflammation is defined as the presence of two or more of the following clinical signs: Erythema (redness) extending ≥1 cm from the wound edges. Edema (swelling) at or around the surgical site. Local warmth compared to adjacent skin. Pain or tenderness reported by the patient or elicited during palpation. Purulent discharge from the incision site.
Time frame: 6 month
recurrence
The recurrence outcome measures the number of participants who experience a reappearance of the external angular dermoid cyst at the surgical site within the 6-month follow-up period after surgical removal. Recurrence is defined as the presence of a palpable mass or radiologically confirmed lesion (via ultrasound or MRI) that exhibits characteristics consistent with a dermoid cyst. This outcome is a critical measure of the long-term efficacy of the surgical intervention and the intraoperative cleaning method (saline vs. 70% ethyl alcohol) in preventing residual cyst material from causing regrowth.
Time frame: 6 month
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2019 to primary completion in Dec 2023, 59 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dermoid Cyst